​

Pfizer (PFE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PFE Stock Forecast

Pfizer (PFE) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $32.33, with a high of $33.00 and a low of $32.00. This represents a 46.16% increase from the last price of $22.12.

$20 $23 $26 $29 $32 $35 High: $33 Avg: $32.33 Low: $32 Last Closed Price: $22.12

PFE Stock Rating

Pfizer stock's rating consensus is Hold, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (40.62%), 18 Hold (56.25%), 1 Sell (3.12%), and 0 Strong Sell (0.00%).

Hold
Total 32 1 18 13 Strong Sell Sell Hold Buy Strong Buy

PFE Price Target Upside V Benchmarks

TypeNameUpside
StockPfizer46.16%
SectorHealthcare Stocks 35.46%
IndustryDrug Manufacturers - General Stocks40.29%

Price Target Trends

1M3M12M
# Anlaysts--10
Avg Price Target--$32.90
Last Closing Price$22.12$22.12$22.12
Upside/Downside--48.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2536131-23
Mar, 2536131-23
Feb, 2537131-24
Jan, 2538131-25
Dec, 2438131-25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 18, 2024Robyn KarnauskasTruist Financial$32.00$25.8923.60%44.67%
Oct 30, 2024Chris ShibutaniGoldman Sachs$33.00$28.4615.95%49.19%
Oct 17, 2024Courtney BreenBernstein$32.00$29.677.85%44.67%
Sep 25, 2024Carter GouldBarclays$32.00$28.9310.61%44.67%
Aug 07, 2024Narumi NakagiriDaiwa$34.00$28.8517.85%53.71%
Jul 31, 2024Mohit BansalWells Fargo$30.00$31.39-4.43%35.62%
Jul 31, 2024Chris ShibutaniGoldman Sachs$34.00$31.398.31%53.71%
Jul 30, 2024Vamil DivanGuggenheim$36.00$30.7217.19%62.75%
Jul 10, 2024Carter GouldBarclays$30.00$27.728.23%35.62%
May 22, 2024Evan SeigermanBMO Capital$36.00$29.6021.62%62.75%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 27, 2025CitigroupNeutralNeutralhold
Feb 28, 2025UBSNeutralNeutraldowngrade
Oct 30, 2024Goldman SachsBuyBuyhold
Oct 23, 2024Wells FargoMarket PerformMarket Performhold
Oct 17, 2024BernsteinMarket Performinitialise
Sep 25, 2024BarclaysEqual-WeightEqual-Weighthold
Sep 20, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 13, 2024BMO CapitalOutperformOutperformhold
Jul 31, 2024Wells FargoEqual-WeightEqual-Weighthold
Jul 31, 2024BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 $6 $7 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.26$3.95$5.59$0.38$1.42----
Avg Forecast$2.83$4.21$6.50$1.55$2.92$2.91$3.01$2.98$2.85
High Forecast$2.93$4.35$6.64$1.66$3.12$3.03$3.92$3.37$2.91
Low Forecast$2.73$4.06$6.29$1.48$2.73$2.46$2.58$2.24$2.77
Surprise %-55.48%-6.18%-14.00%-75.48%-51.37%----

Revenue Forecast

$40B $53B $66B $79B $92B $105B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$41.91B$81.29B$100.33B$58.50B$63.63B----
Avg Forecast$48.20B$81.76B$100.34B$58.78B$63.08B$63.08B$63.06B$62.33B$59.90B
High Forecast$49.46B$83.89B$101.97B$59.18B$63.63B$63.93B$63.14B$62.50B$60.82B
Low Forecast$46.90B$79.56B$97.80B$58.53B$62.67B$62.46B$62.99B$62.17B$58.66B
Surprise %-13.06%-0.58%-0.01%-0.48%0.87%----

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.02B$21.98B$31.37B$2.12B$8.03B----
Avg Forecast$8.71B$24.02B$18.44B$2.13B$16.71B$15.66B$18.56B$12.93B$16.27B
High Forecast$10.45B$24.84B$22.12B$2.56B$17.81B$17.30B$22.37B$19.23B$16.59B
Low Forecast$6.97B$23.18B$14.75B$1.71B$15.60B$14.02B$14.75B$12.79B$15.83B
Surprise %-19.40%-8.52%70.16%-0.70%-51.94%----

PFE Forecast FAQ

Is Pfizer stock a buy?

Pfizer stock has a consensus rating of Hold, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 18 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Pfizer is a neutral investment for most analysts.

What is Pfizer's price target?

Pfizer's price target, set by 32 Wall Street analysts, averages $32.33 over the next 12 months. The price target range spans from $32 at the low end to $33 at the high end, suggesting a potential 46.16% change from the previous closing price of $22.12.

How does Pfizer stock forecast compare to its benchmarks?

Pfizer's stock forecast shows a 46.16% upside, outperforming the average forecast for the healthcare stocks sector (35.46%) and outperforming the drug manufacturers - general stocks industry (40.29%).

What is the breakdown of analyst ratings for Pfizer over the past three months?

  • April 2025: 13.04% Strong Buy, 26.09% Buy, 56.52% Hold, 4.35% Sell, 0% Strong Sell.
  • March 2025: 13.04% Strong Buy, 26.09% Buy, 56.52% Hold, 4.35% Sell, 0% Strong Sell.
  • February 2025: 12.50% Strong Buy, 29.17% Buy, 54.17% Hold, 4.17% Sell, 0% Strong Sell.

What is Pfizer’s EPS forecast?

Pfizer's average annual EPS forecast for its fiscal year ending in December 2025 is $2.91, marking a 104.93% increase from the reported $1.42 in 2024. Estimates for the following years are $3.01 in 2026, $2.98 in 2027, and $2.85 in 2028.

What is Pfizer’s revenue forecast?

Pfizer's average annual revenue forecast for its fiscal year ending in December 2025 is $63.08B, reflecting a -0.86% decrease from the reported $63.63B in 2024. The forecast for 2026 is $63.06B, followed by $62.33B for 2027, and $59.9B for 2028.

What is Pfizer’s net income forecast?

Pfizer's net income forecast for the fiscal year ending in December 2025 stands at $15.66B, representing an 94.99% increase from the reported $8.03B in 2024. Projections indicate $18.56B in 2026, $12.93B in 2027, and $16.27B in 2028.